Holen Sie sich die Stockscreener-App
2.03
5.18%
0.10
Handel nachbörslich:
2.07
0.04
+1.97%
Schlusskurs vom Vortag:
$1.93
Offen:
$1.93
24-Stunden-Volumen:
80,943
Relative Volume:
0.02
Marktkapitalisierung:
$25.00M
Einnahmen:
$130.00K
Nettoeinkommen (Verlust:
$-19.22M
KGV:
-1.0715
EPS:
-1.8946
Netto-Cashflow:
$-18.01M
1W Leistung:
+0.50%
1M Leistung:
+30.97%
6M Leistung:
-60.58%
1J Leistung:
-60.20%
1-Tages-Spanne:
$1.92
$2.07
1-Wochen-Bereich:
$1.85
$2.30
52-Wochen-Spanne:
$1.22
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Firmenname
Serina Therapeutics Inc
Sektor
Branche
Telefon
(256) 327-9630
Adresse
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.03 | 23.77M | 130.00K | -19.22M | -18.01M | -1.8946 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | H.C. Wainwright | Buy |
Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Market Review: What is the dividend yield of Serina Therapeutics IncWeekly Trend Recap & Verified Momentum Stock Alerts - baoquankhu1.vn
Take Profit: What is the dividend yield of Serina Therapeutics IncMarket Growth Report & Free High Return Stock Watch Alerts - baoquankhu1.vn
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit - Sahm
Serina Therapeutics, Inc Announces Novel Lipid Nanoparticles Built On POZ Platform - marketscreener.com
Recap Report: Will PHUN be affected by tariffs2026 PreEarnings & Risk Controlled Swing Alerts - baoquankhu1.vn
Serina says its nanoparticle polymer avoided antibodies in rat study - Stock Titan
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan - Sahm
Serina Therapeutics wins NYSE approval; 2027 listing compliance deadline set - MSN
Serina Therapeutics announces NYSE American acceptance of continued listing compliance plan - marketscreener.com
Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan - TradingView
SER Technical Analysis & Stock Price Forecast - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Serina Therapeutics (SER) files 10-K amendment to correct auditor consent - stocktitan.net
New funding to support Serina’s SER-252 trial in advanced Parkinson’s - Parkinson's News Today
SER Stock Price and Chart — AMEX:SER - TradingView
Serina Therapeutics POZ Drug Delivery Platform: Technology Overview, Pipeline, and Intellectual Property Portfolio - Minichart
Serina Therapeutics' 2025 net loss widens as R&D expenses jump - TradingView
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights - marketscreener.com
Serina Therapeutics (NYSE: SER) posts 2025 loss while funding SER-252 trials - Stock Titan
[10-K] Serina Therapeutics, Inc. Fi... - Stock Titan
Serina Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Parkinson's drug candidate reaches patients as Serina lines up $30M - Stock Titan
Top Executive Makes Notable Move With Serina Therapeutics Stock - TipRanks
Serina Therapeutics CSO Moreadith sells $18,567 in stock - Investing.com
Serina Therapeutics CSO Moreadith sells $18,567 in stock By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options then sells 6,500 shares - Stock Titan
Serina Therapeutics Raises Up to $30 Million to Advance SER-252 Parkinson’s Drug Trial and Secures Additional Funding Opportunities - Minichart
Serina Therapeutics to Present at 38th Annual Roth Conference - National Today
Serina Therapeutics to Present at the 38th Annual Roth Conference - Bitget
Serina Therapeutics Inc appoints Greg Bailey as co-chairman of boardSEC filing - MarketScreener
Serina Therapeutics IncAppoints Greg Bailey As Co-Chairman Of BoardSEC Filing - TradingView — Track All Markets
Serina Therapeutics (SER) lines up $30M private placement plus $33.3M warrant upside - Stock Titan
Serina Therapeutics Inc. Faces Stock Volatility Amid Economic Challenges - StocksToTrade
Risk Check: What is the dividend yield of Serina Therapeutics IncEarnings Recap Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
Serina Therapeutics secures up to $30M in private placement - MSN
Serina Therapeutics Insider Sells $97,500 in Stock - National Today
Top Serina Therapeutics Executive Makes Notable Stock Move - TipRanks
Serina Therapeutics CSO sells $97,500 in shares By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options and sells 39,000 shares - Stock Titan
Serina Therapeutics Inc. Rallies on Dynamic Market Expansion Prospects - timothysykes.com
Serina Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 2BO | US81751A1088 - marketscreener.com
Stock Market Today: Futures Drop Ahead Of 'Triple Witching' Session As Iran Threatens 'Zero Restraint'— FedEx, Super Micro In Focus (UPDATED) - Benzinga
Serina Therapeutics (SER) Stock Jumps 39% Following $63M Financing Deal and Leadership Announcement - MEXC
Serina Therapeutics (SER) Stock Climbs 39% on Private Placement and Greg Bailey Appointment - MEXC
Biotech Microcap Rockets After Securing Major Capital Infusion at Premium Valuation - The Globe and Mail
SER Stock Surges Amid Strategic Acquisitions and Partnerships - StocksToTrade
Serina Therapeutics (SER) Stock Soars 39% After Announcing $63M Funding and Leadership Boost - parameter.io
Serina Therapeutics (SER) Stock Soars 39% After $30M Funding Deal and Leadership Boost - MoneyCheck
Serina Therapeutics’ Stock Hits All-Time Low Amid Financial Challenges - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Finanzdaten der Serina Therapeutics Inc-Aktie (SER)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
Kapitalisierung:
|
Volumen (24h):